💡 Johnson & Johnson: $14.6 billion acquisition strengthens the pharmaceutical giant's position in the neurological drugs market 💊
Johnson & Johnson $JNJ, one of the biggest players in the healthcare industry, has once again shown that growth through strategic acquisitions is their forte.
The company announced last week the purchase of biopharmaceutical firm Intra-Cellular... Read more
I have a portfolio composed mainly of dividend and value stocks, so those positions are similarly large. Tobacco companies pay a super dividend, so $BTI and $MO. But I've had $KO stock for a few years and that pays a nice dividend too.
We use cookies to improve your experience on our site.
3 biotech stocks to watch in 2025
Zobrazit další komentáře
I have$ADMA speculatively 🔥
💡 Johnson & Johnson: $14.6 billion acquisition strengthens the pharmaceutical giant's position in the neurological drugs market 💊
Johnson & Johnson $JNJ, one of the biggest players in the healthcare industry, has once again shown that growth through strategic acquisitions is their forte.
The company announced last week the purchase of biopharmaceutical firm Intra-Cellular...
Read more
Zobrazit další komentáře
It's not a bad business, but I'd rather buy something riskier. Plus this stock isn't growing as mentioned and I don't see why it should start growing.
Which dividend stocks make up the largest part of your portfolio?
Of the dividend stocks, I have a larger position in $MO, $VICI, $O and $KOMB.PR.
Zobrazit další komentáře
I have a portfolio composed mainly of dividend and value stocks, so those positions are similarly large. Tobacco companies pay a super dividend, so $BTI and $MO. But I've had $KO stock for a few years and that pays a nice dividend too.